Latest Asx News

Empire Resources has reported promising assay results from its recent air core drilling at the Yuinmery Copper-Gold Project, extending known mineralisation and identifying new gold targets for 2026 exploration.

Indiana Resources has reported strong assay results confirming the continuation of high-grade gold mineralisation at depth within its Minos Gold Project in South Australia, alongside significant silver mineralisation. The company is advancing a 7,000m air-core drilling program at nearby prospects, supporting its hub and spoke development strategy.

Macquarie Group Limited has announced an ordinary dividend of AUD 2.80 per share for the half-year ending September 2025, accompanied by a fully franked component and a Dividend Reinvestment Plan available to shareholders.

Macquarie Group Limited reported a 3% increase in profit for the half year ended 30 September 2025, driven by strong performances in asset management and capital advisory, while declaring a 35% franked interim dividend of $2.80 per share.

Warriedar Resources shareholders have overwhelmingly approved a scheme of arrangement for acquisition by Capricorn Metals, clearing a key hurdle ahead of final court approval and delisting.

Finexia Financial Group Limited (ASX – FNX) has had its trading suspension lifted immediately following its public response to recent media speculation. The reinstatement marks a pivotal moment for the financial group’s market activity.

Finexia Financial Group has formally ended preliminary discussions with Salter Brothers regarding a potential reverse listing and is seeking immediate reinstatement of its ASX securities.

VGI Partners Global Investments Limited has announced an on-market buy-back of its ordinary shares, set to begin in late November 2025 and run for a full year. The buy-back offers a flexible approach without fixed volume limits or a set price, signaling a strategic capital management move.

hummgroup and The Abercrombie Group have mutually agreed to end discussions on an unsolicited acquisition proposal, with TAG withdrawing its offer that included a 35% premium. The Independent Board Committee now shifts focus to operational execution and shareholder value.

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

FSI’s FY2025 portfolio posted a modest 5.0% return, trailing the ASX All Ordinaries Index, while maintaining dividend growth and planning a strategic move into pre-IPO investments.